Coronavirus vaccine update: The month of December has kicked-off with a good news - Today, the United Kingdom became the first country to approve a vaccine against coronavirus, which has killed 1,487,701 people across the globe and has infected over 64 million. UK's approval of Pfizer/BioNTech vaccine has paved the way for mass vaccinations, which will begin from next week. The vaccine claims to offer up to 95 per cent protection against corona.
Other than Pfizer, Moderna vaccine candidate is said to be 94.5% effective at preventing Covid and is likely to be approved for emergency rollout in the US in few days. Meanwhile, India's 'Covaxin', Oxford-Astrazeneca, Johnson & Johnson, Russia's Sputnik V Covid-19 vaccones have shown promising result at different stages of trial.
Take a look at Covid vaccine progress across the world, including India
The UK on Wednesday became the first country to approve the Pfizer/BioNTech vaccine against COVID-19, paving the way for mass vaccinations against the deadly novel coronavirus. The British regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), says the jab, which claims to offer up to 95 per cent protection against COVID-19 illness, is safe for roll out.
The joint vaccine, produced by American pharmaceutical giant Pfizer and German biotech firm BioNTech, had recently claimed trials suggested it works well in people of all ages, races and ethnicities. The UK is expected to receive a total of 40 million doses by the end of 2021, enough to vaccinate up to a third of the population.
6. Mexico set to sign deal with Pfizer
Mexico's government is set to sign a contract on Wednesday with pharmaceutical company Pfizer for the delivery of its coronavirus vaccine.
Pfizer has submitted the details about its vaccine to Mexico's health regulator, Cofepris, and the country's foreign minister last month said the government expects the vaccine to reach Mexico in December.
Mumbai-based drugmajor Wockhardt said it is in talks with global vaccine makers for contract manufacturing drug substances for making vaccines as well as do the fill and finish doses out of its Indian site which has a capacity for one billion doses annually.
Drug substances are the raw material for making vaccines.
8. Pfizer-BioNTech apply for EU emergency authorisation for Covid-19 vaccine
Pfizer Inc and BioNTech have applied to the European drugs regulator for conditional authorization of their COVID-19 vaccine, following similar steps in the United States and Britain, the companies said on Tuesday. The application to the European Medicines Agency (EMA) comes after the companies applied for U.S. approval on Nov. 20, taking them a step closer to launching their vaccine.
9. India coronavirus vaccine latest news
'Indian govt never talked of vaccinating entire population with Covid-19 vaccine'
There was never any talk of inoculating the whole population of the country with Covid-19 vaccine, the Centre said on Tuesday said. Union Health Secretary Rajesh Bhushan said there was never a talk about inoculating the whole population of the country with COVID-19 vaccine. "I just want to make this clear that the government has never spoken about vaccinating the entire country. It's important that we discuss such scientific issues, based on factual information only and then analyse it," said Bhushan.